Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 janv. 2020 09h00 HE | Source: NeoTherma Oncology

NeoTherma Oncology Announces FDA IDE Submission to Permit Investigational Treatment of Pancreatic Cancer Patients with Its FDA-Designated Breakthrough Device, the VectRx™ Thermal Oncology System

WICHITA, Kan., Jan. 09, 2020 (GLOBE NEWSWIRE) -- NeoTherma Oncology (NTO), a privately held medical device company developing novel non-invasive treatments for solid tumors, today announces they...
21 août 2018 12h00 HE | Source: NeoTherma Oncology

NeoTherma Oncology Receives NCI Grant to Advance VectRx™ MRI Thermometry

WICHITA, Kan., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the...
14 août 2018 15h04 HE | Source: NeoTherma Oncology

NeoTherma Oncology Raises $6 Million to Advance VectRx™ to Human Testing

WICHITA, Kan., Aug. 14, 2018 (GLOBE NEWSWIRE) -- NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the...
10 mai 2017 16h33 HE | Source: NeoTherma Oncology

NeoTherma Oncology Reports on the Safety and Effectiveness of RF-generated Heat Delivery in Preclinical Animal Studies with the Vectron TTx Thermal Device intended for Treatment of Deep Solid Tumors at Society for Thermal Medicine Annual Meeting

WICHITA, Kan., May 10, 2017 (GLOBE NEWSWIRE) -- NeoTherma Oncology, (NTO) a privately held medical device company developing novel non-invasive treatments for solid tumors, reported the results of a...
04 avr. 2017 10h06 HE | Source: NeoTherma Oncology

NeoTherma Oncology Announces FDA Granted Its Vectron Thermal Device for Treatment of Pancreatic Cancer Breakthrough Device Designation within Expedited Access Pathway

WICHITA, Kan., April 04, 2017 (GLOBE NEWSWIRE) -- NeoTherma Oncology, (NTO) a privately held medical device company developing novel non-invasive treatments for solid tumors, today announces that...